Product Portfolio
Dessglim M1
Dual action sulfonylurea and biguanide combination for optimal blood glucose management.
Dessglim M2
Higher strength sustained release Glimepiride Metformin formulation for adult Type 2 diabetic patients.
Stadess DM
Triple combination SGLT2 inhibitor, DPP-4 inhibitor, and biguanide extended-release tablet for wider glycemic control in Type 2 Diabetes.
Stadess M
Synergistic anti-diabetic tablet for sustained blood sugar regulation and metabolic balance.
Vildess-M 500
DDP-4 inhibitor with metformin for effective 24-hour glycemic control without hypoglycemia risk.
Voglidess GM1
Triple drug anti-diabetic therapy to control postprandial glucose spikes and fasting blood sugar levels.
Voglidess GM2
Wider triple action oral hypoglycemic combination for refractory Type 2 Diabetes.